Yachmetz Philip K

Avg. Two Year Performance

133% Avg. Purchase Return
53% Compound
35% Avg. Sale Return
16% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return10%(7%)(22%)6%133%
Purchase Success Rate1 of 21 of 21 of 21 of 21 of 2
Average Sale Return1%< 1%(7%)15%35%
Sale Success Rate11 of 1811 of 188 of 189 of 1811 of 18

Savient Pharmaceuticals Inc.

Drugs » Biotechnology

Co-President and CBO:

Holdings: 90.55K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Teligent, Inc.

Drugs » Biotechnology

EVP, Chief Legal Off, Corp Sec:

Holdings: 5.18K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Progenics Pharmaceuticals I...

Drugs » Biotechnology

VP, General Counsel:

Holdings: 7.9K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--